HYBRID EVENT: Join us in person in London, UK or attend virtually from anywhere.
Covid and Its Impact on Cancer

The first half of 2020 saw the advent of coronavirus disease 2019 (COVID-19) as a pandemic, which had an immediate and significant impact on cancer care. The COVID-19 pandemic has had a wide-ranging detrimental effect on cancer care, with variable degrees of severity in different places throughout the world. Patients with cancer are a vulnerable population, and they are exposed to a variety of problems during pandemics, including infection susceptibility and disruption of their cancer or regular medical care. Potential cardiovascular complications in cancer patients who have also been infected with SARS-CoV-2 are one of the most pressing concerns for clinicians. The renin-angiotensin-aldosterone system (RAAS) is another area of concern in COVID-19 positive cancer patients.

•              RAAS
•              Cardiovascular complications
•              Key biomarkers in COVID-19 cancer patients
•              Oncology Consultation and Care During and Post-COVID-19

Committee Members
Speaker at International Conference on Clinical & Translational Oncology 2027 - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Speaker at International Conference on Clinical & Translational Oncology 2027 - Michael Thompson

Michael Thompson

University of Toronto, Canada
Speaker at International Conference on Clinical & Translational Oncology 2027 - Alain Chapel

Alain Chapel

Institute Of Radiological Protection And Nuclear Safety, France

Submit your abstract Today

Facebook Twitter XTwitter Youtube
Whatsapp